Gilead Sciences Gross Carrying Amount decreased by 0.1% to $31.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.1%, from $31.88B to $31.86B. Over 5 years (FY 2020 to FY 2025), Gross Carrying Amount shows an upward trend with a 6.8% CAGR.
Higher values indicate significant investment in intellectual property or acquisitions, while stability suggests a consistent asset base.
The total historical cost of intangible assets with a defined useful life, such as patents, customer relationships, or s...
Standard across capital-intensive industries; peers with high M&A activity typically show larger balances.
other_finite_lived_intangible_assets_gross| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.72B | $25.72B | $25.92B | $25.94B | $25.92B | $25.92B | $25.79B | $31.89B | $31.89B | $31.89B | $31.82B | $31.82B | $31.82B | $31.88B | $31.88B | $31.88B | $31.88B | $31.88B | $31.89B | $31.86B |
| QoQ Change | — | +0.0% | +0.8% | +0.1% | -0.1% | +0.0% | -0.5% | +23.6% | +0.0% | +0.0% | -0.2% | +0.0% | +0.0% | +0.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.1% |
| YoY Change | — | — | — | — | +0.8% | +0.8% | -0.5% | +23.0% | +23.1% | +23.1% | +23.4% | -0.2% | -0.2% | -0.0% | +0.2% | +0.2% | +0.2% | +0.0% | +0.0% | -0.1% |